Novotech

Prospection Pty Ltd, founded in 2012 and based in Sydney, Australia, specializes in healthcare data analytics through its software as a service (SaaS) platforms. The company offers solutions such as PharmDash, which provides real-world evidence by analyzing patient treatment regimens and drug effectiveness, and PharmMap, which integrates commercial and operational data using geospatial mapping. Prospection employs predictive analytics and machine learning to derive insights from extensive healthcare data, assisting pharmaceutical companies, research institutes, and healthcare providers in improving patient outcomes. The company collaborates with various stakeholders in over 70 therapy programs, including immuno-oncology and infectious diseases, primarily within Australia and the Asia Pacific region.

ObvioHealth is a clinical research platform focused on enhancing the efficiency of the clinical trial process. By leveraging advanced technology, the platform enables sponsors to obtain superior data while providing participants with a more convenient trial experience, allowing them to engage in virtual clinical trials from their homes. Supported by SPRIM, a global leader in health-centric innovation with extensive expertise in medical and life sciences, ObvioHealth benefits from a strong foundation in digital capabilities and regulatory knowledge. This collaboration aims to drive disruptive innovations and facilitate new market entries, ultimately striving to deliver tangible results in the clinical research landscape.